Company Overview and News

 
David Edgerton, Burger King co-founder helped make the Whopper

2h smh.com.au
David Edgerton, a serial entrepreneur who helped turn a South Florida hamburger franchise into Burger King but who came to regret selling the company before it became a whopping fast-food empire, has died at a hospital in Miami. He was 90.
Upvote Downvote

 
Spat breaks out between Tim Hortons franchisee factions over public complaints

7h cbc.ca
The Tim Hortons franchisee advisory board is slamming a group representing at least half of the brand's restaurant owners for publicly making complaints about their parent company Restaurant Brands International Inc.
Upvote Downvote

 
Starbucks Corporation Will Always Try to Do the Right Thing

2018-04-18 investorplace
Starbucks Corporation (NASDAQ:SBUX) CEO Kevin Johnson is currently facing his biggest challenge since replacing Howard Schultz as the company’s chief executive a year ago.
Upvote Downvote

 
Tim Hortons hit by supply delays

2018-04-17 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
Tim Hortons to move its Canadian head office

2018-04-17 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
PRESS DIGEST-Canada - April 13

2018-04-13 reuters
April 13 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
Upvote Downvote

 
Ottawa to investigate franchisee complaints against Tim Hortons parent company

2018-04-13 cbc.ca
The federal government says it's looking into concerns raised by some Tim Hortons franchisees about the potential violation of terms Ottawa placed on a deal that saw their parent company taken over by a Brazilian firm.
Upvote Downvote

 
Feds investigating Tim Hortons owner over claims they’re failing to honour commitments

2018-04-13 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
Franchisee loses licence amid high profile spat with Tim Hortons

2018-04-10 cbc.ca
An association representing some Tim Hortons franchisees says a prominent member has had his licence renewal denied amid ongoing tensions with the company.
Upvote Downvote

 
Top Dividend Raises And Cuts For March 2018

2018-04-09 seekingalpha
Dividend growth investing is a popular model followed by the investing community to build assets. Companies which not only pay dividends, but raise them year after year have been shown to perform better overall for investor returns.
Upvote Downvote

 
Restaurant Brands International - 100% Franchise, 100% Dividend

2018-04-08 seekingalpha
The recent dividend increase pushed the yield over 3%, this could become a good idea for income-seeking investor.
Upvote Downvote

 
Can McDonald’s Stock Continue Its Momentum in 2018?

2018-04-04 editors.aws.marketrealist
McDonald’s (MCD) had a good year in 2017, as its stock returned 41.4%. The company’s 2017 SSSG (same-store sales growth) was its strongest in the last five years. The company had outperformed analysts’ SSSG estimates in all four quarters.
Upvote Downvote

 
Zacks.com highlights: athenahealth, Applied Materials, Pioneer Natural Resources and TriNet Group

2018-04-04 zacks
Chicago, IL – April 4, 2018 - Stocks in this week’s article include: athenahealth Inc (ATHN - Free Report) , Applied Materials Inc. (AMAT - Free Report) , Pioneer Natural Resources Company (PXD - Free Report) and TriNet Group Inc. (TNET - Free Report) .
Upvote Downvote

 
Zacks Investment Ideas feature highlights: Fiat Chrysler, General Motors and Tesla Motors

2018-04-04 zacks
Chicago, IL – April 4, 2018 – Today, Zacks Investment Ideas feature highlights Features: Fiat Chrysler (FCAU - Free Report) , General Motors (GM - Free Report) and Tesla Motors (TSLA - Free Report) .
Upvote Downvote

 
The Zacks Analyst Blog Highlights: Facebook, Twitter, Amazon, Alphabet and Apple

2018-04-04 zacks
Chicago, IL – April 4, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Facebook (FB - Free Report) , Twitter (TWTR - Free Report) , Amazon (AMZN - Free Report) , Alphabet (GOOGL - Free Report) and Apple (AAPL - Free Report) .
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...